CALT - Calliditas Therapeutics GAAP EPS of -SEK 3.62 revenue of SEK 64M August, 18 2022 01:36 AM Calliditas Therapeutics AB Calliditas Therapeutics press release ( NASDAQ: CALT ): Q2 GAAP EPS of -SEK 3.62. Revenue of SEK 64M. Cash amounted to SEK 846.8M and SEK 709.3M as of June 30, 2022 and 2021 respectively. For further details see: Calliditas Therapeutics GAAP EPS of -SEK 3.62, revenue of SEK 64M